These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31521488)

  • 1. The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease.
    Randolph C
    Am J Geriatr Psychiatry; 2019 Dec; 27(12):1428-1432. PubMed ID: 31521488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding.
    Plancher G; Tirard A; Gyselinck V; Nicolas S; Piolino P
    Neuropsychologia; 2012 Apr; 50(5):592-602. PubMed ID: 22261400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
    Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
    JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
    Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
    Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease.
    Schindler SE; Jasielec MS; Weng H; Hassenstab JJ; Grober E; McCue LM; Morris JC; Holtzman DM; Xiong C; Fagan AM
    Neurobiol Aging; 2017 Aug; 56():25-32. PubMed ID: 28482211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
    Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.
    Buckley RF; Maruff P; Ames D; Bourgeat P; Martins RN; Masters CL; Rainey-Smith S; Lautenschlager N; Rowe CC; Savage G; Villemagne VL; Ellis KA;
    Alzheimers Dement; 2016 Jul; 12(7):796-804. PubMed ID: 26852195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new assessment for episodic memory. Episodic memory test and caregiver's episodic memory test].
    Ojea Ortega T; González Álvarez de Sotomayor MM; Pérez González O; Fernández Fernández O
    Neurologia; 2013 Oct; 28(8):488-96. PubMed ID: 23246215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patients.
    Ciarmiello A; Tartaglione A; Giovannini E; Riondato M; Giovacchini G; Ferrando O; De Biasi M; Passera C; Carabelli E; Mannironi A; Foppiano F; Alfano B; Mansi L
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):288-296. PubMed ID: 30244387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective cognitive impairment: Towards early identification of Alzheimer disease.
    Garcia-Ptacek S; Eriksdotter M; Jelic V; Porta-Etessam J; Kåreholt I; Manzano Palomo S
    Neurologia; 2016 Oct; 31(8):562-71. PubMed ID: 23601758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
    Alegret M; García-Gutiérrez F; Muñoz N; Espinosa A; Ortega G; Lleonart N; Rodríguez I; Rosende-Roca M; Pytel V; Cantero-Fortiz Y; Rentz DM; Marquié M; Valero S; Ruiz A; Butler C; Boada M
    J Alzheimers Dis; 2024; 97(3):1173-1187. PubMed ID: 38217602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer's dementia.
    van Geldorp B; Heringa SM; van den Berg E; Olde Rikkert MG; Biessels GJ; Kessels RP
    J Clin Exp Neuropsychol; 2015; 37(5):538-48. PubMed ID: 26011711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing.
    Buckley RF; Saling MM; Irish M; Ames D; Rowe CC; Lautenschlager NT; Maruff P; Macaulay SL; Martins RN; Masters CL; Rainey-Smith SR; Rembach A; Savage G; Szoeke C; Ellis KA
    J Alzheimers Dis; 2014; 40(3):551-61. PubMed ID: 24496075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.
    Aschenbrenner AJ; Balota DA; Fagan AM; Duchek JM; Benzinger TL; Morris JC
    J Int Neuropsychol Soc; 2015 Sep; 21(8):573-83. PubMed ID: 26416094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
    Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.